跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,245 条关于
“cholesteryl-ester transfer protein”
全部
16,245
临床试验
7,931
药物
1,582
机构
68
资讯
6,664
2年前
Obicetrapib Shows Promise in Reducing LDL and Lp(a) Levels for Dyslipidemia Treatment
2年前
NewAmsterdam Pharma Announces 2024 Strategic Priorities and Clinical Trial Updates
去年
Obicetrapib Shows Promise in Lowering LDL Cholesterol and Lp(a) in HeFH Patients
去年
Obicetrapib Demonstrates Significant LDL-C Reduction in HeFH Patients in Phase III BROOKLYN Trial
去年
NLS Pharmaceutics and NewAmsterdam Pharma File Mixed Securities Shelves Worth $75M and $500M Respectively
去年
NewAmsterdam Pharma Advances Obicetrapib Program, Outlines 2025 Priorities
去年
NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results
8个月前
NewAmsterdam Pharma Advances Obicetrapib Development with Promising Alzheimer's Biomarker Data and Multiple Phase 3 Trials
11个月前
Precision Cardiovascular Medicine Emerges as New Paradigm to Address Disease Heterogeneity and Drug Development Challenges
去年
Jongkundang Receives FDA Clearance for Phase 1 Trial of Novel Hyperlipidemia Drug CKD-508
第 1 页，共 667 页
上一页
下一页
